Association between ocular herpes simplex virus and topical ocular hypotensive therapy

Journal of Glaucoma

Volumn 13, Issue 5, 2004, Pages 361-364

  Bean, Gerald ^a   Reardon, Gregory ^b   Zimmerman, Thom J ^a,b,c  

^a PFIZER INC   (United States)

^b Informagenics LLC   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

Glaucoma; Ocular herpes simplex virus; Ocular hypotensive therapy; Prevalence

Indexed keywords

ADRENALIN; ANTIHYPERTENSIVE AGENT; APRACLONIDINE; BETAXOLOL; BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; CARBACHOL; CARTEOLOL; DEMECARIUM; DIPIVEFRINE; DORZOLAMIDE; ECOTHIOPATE IODIDE; LATANOPROST; LEVOBUNOLOL; METIPRANOLOL; PILOCARPINE; TIMOLOL; TRAVOPROST; UNOPROSTONE ISOPROPYL ESTER;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; EYE INFECTION; FEMALE; GLAUCOMA; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; INFECTION RISK; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OCULAR HERPES SIMPLEX; PHARMACY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS INFECTION;

ADULT; COHORT STUDIES; FEMALE; HUMANS; KERATITIS, HERPETIC; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PREVALENCE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 4644247436     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000133146.52310.3d     Document Type: Article

References (15)

1. Liesegang TJ. Herpes simplex virus epidemiology and ocular importance. Cornea. 2001;20:1-13.
2. Liesegang TJ, Melton LJ III, Daly PJ, et al. Epidemiology of ocular herpes simplex: incidence in Rochester, Minn. 1950 through 1982. Arch Ophthalmol. 1989;107:1155-1159.
3. Dios Castro E, Maquet Dusart JA. Latanoprost-associated recurrent herpes simplex keratitis. Arch Soc Esp Oftalmol. 2000;75:775-778.
4. Ekatomatis P. Herpes simplex dendritic keratitis after treatment with latanoprost for primary open angle glaucoma. Br J Ophthalmol. 2001;85: 1008-1009.
5. Wand M, Gilbert CM, Liesegang TJ. Latanoprost and herpes simplex keratitis. Am J Ophthalmol. 1999;127:602-604.
6. Haruta Y, Rootman DS, Hill JM. Recurrent HSV-1 corneal epithelial lesions induced by timolol iontophoresis in latently infected rabbits. Invest Ophthalmol Vis Sci. 1988;29:387-392.
7. Hill JM, Shimomura Y, Dudley JB, et al. Timolol induces HSK-1 ocular shedding in the latently infected rabbit. Invest Ophthalmol Vis Sci. 1987; 28:585-590.
8. Kaufman HE, Varnell ED, Thompson HW. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit. Am J Ophthalmol. 1999;127:531-536.
9. Kaufman HE, Varnell ED, Toshida H, et al. Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit. Am J Ophthalmol. 2001;131:643-646.
10. Rootman DS, Haruta Y, Hill JM. Reactivation of HSV-1 in primates by transcorneal iontophoresis of adrenergic agents. Invest Ophthalmol Vis Sci. 1990;31:597-600.
11. Kroll DM, Schuman JS. Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma. Am J Ophthalmol. 2002;133:401-403.
12. Morales J, Shihab ZM, Brown SM, et al. Herpes simplex virus dermatitis in patients using latanoprost. Am J Ophthalmol. 2001;132:114-116.
13. Camras CB. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit; latanoprost and herpes simplex keratitis. Am J Ophthalmol. 2000;129:271-272.
14. van Puijenbroek EP. Potentials and limitations of spontaneous reports of adverse drug reactions. Presented at: Training course Netherlands Pharmacovigilance Centre Lareb ISoP. Paris: January 16-17, 2003.
15. Gordon YJ, Yates KA, Mah FS, et al. The effects of Xalatan® on the recovery of ocular herpes simplex virus type 1 (HSV-1) in the induced reactivation and spontaneous shedding rabbit models. J Ocul Pharmacol Ther. 2003;19:233-245.